Search Results
Found 1 results
510(k) Data Aggregation
(23 days)
A1CNOW FOR RX HOME USE
The AlcNow™ test provides quantitative measurement of the percent of glycated hemoglobin in fresh capillary or venous whole blood samples. The test is for prescription home use by people with diabetes to monitor glycemic control.
Not Found
This is a 510(k) premarket notification for the A1cNow™ device, a glycosylated hemoglobin assay for prescription home use. There is no information in the provided text that describes the acceptance criteria, or a study that proves the device meets the acceptance criteria. The document is primarily a letter from the FDA confirming the device's substantial equivalence to legally marketed predicate devices.
Therefore, I cannot provide the requested information in the format requested.
Ask a specific question about this device
Page 1 of 1